Obesity is an independent prognostic variable in colon cancer survivors

Frank A Sinicrope, Nathan R. Foster, Daniel J. Sargent, Michael J. O'Connell, Cathryn Rankin

Research output: Contribution to journalArticle

142 Citations (Scopus)

Abstract

Purpose: Obesity is associated with an increased risk of colon cancer. However, the influence of body mass index (BMI) on the prognosis of colon cancer survivors and its relationship to gender remains unknown. Experimental Design: BMI (kg/m2) was categorized in patients with tumor-node-metastasis stage II and III colon carcinomas (n = 4,381) enrolled in seven randomized trials of 5-fluorouracil-based adjuvant chemotherapy. Cox proportional hazards models were used to determine the association of BMI with disease-free survival (DFS) and overall survival (OS). Results: Among colon cancer patients, 868 (20%) were obese (BMI,≥30 kg/m2), of which 606 were class 1 (BMI, 30-34 kg/m2) and 262 were class 2,3 (BMI, ≥35 kg/m2). Obese versus normal-weight patients were more likely to be younger, have distal tumors, show intact DNA mismatch repair, and have more lymph node metastases (P < 0.017). In a multivariate analysis, BMI was significantly associated with both DFS (P = 0.030) and OS (P = 0.0017). Men with class 2,3 obesity showed reduced OS compared with normal-weight men [hazard ratio, 1.35; 95% confidence interval, 1.02-1.79; P = 0.039]. Women with class I obesity had reduced OS [hazard ratio, 1.24; 95% confidence interval, 1.01-1.53; P = 0.045] compared with normal-weight women. Overweight status was associated with improved OS in men (P = 0.006), and underweight women had significantly worse OS (P = 0.019). BMI was not predictive of therapeutic benefit. Conclusions: Obesity is an independent prognostic variable in colon cancer survivors and shows gender-related differences. These data suggest that obesity-related biological factors can influence clinical outcome.

Original languageEnglish (US)
Pages (from-to)1884-1893
Number of pages10
JournalClinical Cancer Research
Volume16
Issue number6
DOIs
StatePublished - Mar 15 2010

Fingerprint

Colonic Neoplasms
Survivors
Body Mass Index
Obesity
Survival
Weights and Measures
Disease-Free Survival
Confidence Intervals
Neoplasm Metastasis
DNA Mismatch Repair
Thinness
Biological Factors
Adjuvant Chemotherapy
Proportional Hazards Models
Fluorouracil
Neoplasms
Colon
Research Design
Multivariate Analysis
Lymph Nodes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Obesity is an independent prognostic variable in colon cancer survivors. / Sinicrope, Frank A; Foster, Nathan R.; Sargent, Daniel J.; O'Connell, Michael J.; Rankin, Cathryn.

In: Clinical Cancer Research, Vol. 16, No. 6, 15.03.2010, p. 1884-1893.

Research output: Contribution to journalArticle

Sinicrope, Frank A ; Foster, Nathan R. ; Sargent, Daniel J. ; O'Connell, Michael J. ; Rankin, Cathryn. / Obesity is an independent prognostic variable in colon cancer survivors. In: Clinical Cancer Research. 2010 ; Vol. 16, No. 6. pp. 1884-1893.
@article{10b3e283c27d484e9dcaa9dc8e134fad,
title = "Obesity is an independent prognostic variable in colon cancer survivors",
abstract = "Purpose: Obesity is associated with an increased risk of colon cancer. However, the influence of body mass index (BMI) on the prognosis of colon cancer survivors and its relationship to gender remains unknown. Experimental Design: BMI (kg/m2) was categorized in patients with tumor-node-metastasis stage II and III colon carcinomas (n = 4,381) enrolled in seven randomized trials of 5-fluorouracil-based adjuvant chemotherapy. Cox proportional hazards models were used to determine the association of BMI with disease-free survival (DFS) and overall survival (OS). Results: Among colon cancer patients, 868 (20{\%}) were obese (BMI,≥30 kg/m2), of which 606 were class 1 (BMI, 30-34 kg/m2) and 262 were class 2,3 (BMI, ≥35 kg/m2). Obese versus normal-weight patients were more likely to be younger, have distal tumors, show intact DNA mismatch repair, and have more lymph node metastases (P < 0.017). In a multivariate analysis, BMI was significantly associated with both DFS (P = 0.030) and OS (P = 0.0017). Men with class 2,3 obesity showed reduced OS compared with normal-weight men [hazard ratio, 1.35; 95{\%} confidence interval, 1.02-1.79; P = 0.039]. Women with class I obesity had reduced OS [hazard ratio, 1.24; 95{\%} confidence interval, 1.01-1.53; P = 0.045] compared with normal-weight women. Overweight status was associated with improved OS in men (P = 0.006), and underweight women had significantly worse OS (P = 0.019). BMI was not predictive of therapeutic benefit. Conclusions: Obesity is an independent prognostic variable in colon cancer survivors and shows gender-related differences. These data suggest that obesity-related biological factors can influence clinical outcome.",
author = "Sinicrope, {Frank A} and Foster, {Nathan R.} and Sargent, {Daniel J.} and O'Connell, {Michael J.} and Cathryn Rankin",
year = "2010",
month = "3",
day = "15",
doi = "10.1158/1078-0432.CCR-09-2636",
language = "English (US)",
volume = "16",
pages = "1884--1893",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - Obesity is an independent prognostic variable in colon cancer survivors

AU - Sinicrope, Frank A

AU - Foster, Nathan R.

AU - Sargent, Daniel J.

AU - O'Connell, Michael J.

AU - Rankin, Cathryn

PY - 2010/3/15

Y1 - 2010/3/15

N2 - Purpose: Obesity is associated with an increased risk of colon cancer. However, the influence of body mass index (BMI) on the prognosis of colon cancer survivors and its relationship to gender remains unknown. Experimental Design: BMI (kg/m2) was categorized in patients with tumor-node-metastasis stage II and III colon carcinomas (n = 4,381) enrolled in seven randomized trials of 5-fluorouracil-based adjuvant chemotherapy. Cox proportional hazards models were used to determine the association of BMI with disease-free survival (DFS) and overall survival (OS). Results: Among colon cancer patients, 868 (20%) were obese (BMI,≥30 kg/m2), of which 606 were class 1 (BMI, 30-34 kg/m2) and 262 were class 2,3 (BMI, ≥35 kg/m2). Obese versus normal-weight patients were more likely to be younger, have distal tumors, show intact DNA mismatch repair, and have more lymph node metastases (P < 0.017). In a multivariate analysis, BMI was significantly associated with both DFS (P = 0.030) and OS (P = 0.0017). Men with class 2,3 obesity showed reduced OS compared with normal-weight men [hazard ratio, 1.35; 95% confidence interval, 1.02-1.79; P = 0.039]. Women with class I obesity had reduced OS [hazard ratio, 1.24; 95% confidence interval, 1.01-1.53; P = 0.045] compared with normal-weight women. Overweight status was associated with improved OS in men (P = 0.006), and underweight women had significantly worse OS (P = 0.019). BMI was not predictive of therapeutic benefit. Conclusions: Obesity is an independent prognostic variable in colon cancer survivors and shows gender-related differences. These data suggest that obesity-related biological factors can influence clinical outcome.

AB - Purpose: Obesity is associated with an increased risk of colon cancer. However, the influence of body mass index (BMI) on the prognosis of colon cancer survivors and its relationship to gender remains unknown. Experimental Design: BMI (kg/m2) was categorized in patients with tumor-node-metastasis stage II and III colon carcinomas (n = 4,381) enrolled in seven randomized trials of 5-fluorouracil-based adjuvant chemotherapy. Cox proportional hazards models were used to determine the association of BMI with disease-free survival (DFS) and overall survival (OS). Results: Among colon cancer patients, 868 (20%) were obese (BMI,≥30 kg/m2), of which 606 were class 1 (BMI, 30-34 kg/m2) and 262 were class 2,3 (BMI, ≥35 kg/m2). Obese versus normal-weight patients were more likely to be younger, have distal tumors, show intact DNA mismatch repair, and have more lymph node metastases (P < 0.017). In a multivariate analysis, BMI was significantly associated with both DFS (P = 0.030) and OS (P = 0.0017). Men with class 2,3 obesity showed reduced OS compared with normal-weight men [hazard ratio, 1.35; 95% confidence interval, 1.02-1.79; P = 0.039]. Women with class I obesity had reduced OS [hazard ratio, 1.24; 95% confidence interval, 1.01-1.53; P = 0.045] compared with normal-weight women. Overweight status was associated with improved OS in men (P = 0.006), and underweight women had significantly worse OS (P = 0.019). BMI was not predictive of therapeutic benefit. Conclusions: Obesity is an independent prognostic variable in colon cancer survivors and shows gender-related differences. These data suggest that obesity-related biological factors can influence clinical outcome.

UR - http://www.scopus.com/inward/record.url?scp=77949697892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949697892&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-09-2636

DO - 10.1158/1078-0432.CCR-09-2636

M3 - Article

C2 - 20215553

AN - SCOPUS:77949697892

VL - 16

SP - 1884

EP - 1893

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 6

ER -